BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.98
+0.08 (0.90%)
Sep 4, 2026, 4:00 PM EDT - Market closed
BBOT Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $18 | Buy | Reiterates | $18 | +100.45% | Aug 17, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $27 → $25 | Buy | Reiterates | $27 → $25 | +178.40% | Aug 14, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +178.40% | Aug 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $22 | Buy | Reiterates | $22 | +144.99% | Aug 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $23 | Buy | Reiterates | $23 | +156.12% | Aug 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $21 | Buy | Maintains | $21 | +133.85% | Aug 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $23 | Buy | Maintains | $23 | +156.12% | May 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $29 | Buy | Reiterates | $29 | +222.94% | May 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.